Showing results (31-40 of 452) with videos related to
Sort By:
Pageof 46
Clinical Physiology and Biochemistry|January 1, 1986
Rat ventral prostate cell lysis at 2 degrees CK M Anderson, M RubensteinThe Prostate|September 1, 1995
Orthotopic placement of the Dunning R3327 AT-3 prostate tumor in the Copenhagen X Fischer ratM Rubenstein, R Saffrin, M Shaw, et al.Urological Research|January 1, 1990
An immunohistologic characterization of human prostatic atypical hyperplasiaP Chou, V Ray, M Shaw, et al.Journal of Surgical Oncology|July 1, 1995
Renal cell carcinoma: comparison of the TNM and Robson stage groupingsP Guinan, R Saffrin, D Stuhldreher, et al.Methods and Findings in Experimental and Clinical Pharmacology|December 1, 1996
Antitumor effect of CPT-11, a new derivative of camptothecin, against human prostate cancer (PC-3) in vitro and prostate rat tumor (AT-3) in vivoG Lievano, Y Mirochnik, M Rubenstein, et al.Journal of Surgical Oncology|November 1, 1989
Evaluation of cytokeratin markers to differentiate between benign and malignant prostatic tissueP Guinan, M Shaw, P Targonski, et al.Journal of Surgical Oncology|January 1, 1991
Characterization of cellular infiltrates in the rat urinary bladder following BCG and thiotepa intravesical therapyM Shaw, C F McKiel, V Ray, et al.Journal of the National Medical Association|August 5, 2000
Changes in radical prostatectomy and radiation therapy rates for African Americans and whitesM Shaw, L Elterman, M Rubenstein, et al.Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|March 1, 1997
Survival of Mexican-American males with seminomaD Di Domenico, P Bridges, R Sharifi, et al.Oncology|January 1, 1982
Mithramycin impairs the release of 45Ca from bone induced by prostaglandin E2 or multiple myeloma sera. Implications for a novel means of local tumor controlK M Anderson, M Rubenstein, H Sky-PeckPageof 46